2.8500 +0.02 (0.71%)
Pre-Market: 4:37AM EDT
Previous Close | 2.7800 |
Open | 2.9800 |
Bid | 0.0000 x 1000 |
Ask | 0.0000 x 900 |
Day's Range | 2.7501 - 3.0400 |
52 Week Range | 1.4000 - 4.2300 |
Volume | 1,320,475 |
Avg. Volume | 2,022,096 |
Market Cap | 117.213M |
Beta (5Y Monthly) | 1.61 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.7850 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.33 |
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced that the Company has presented a poster at the AACR Annual Meeting, which is being held April 10-15 on a virtual basis."
NEW YORK, NY / ACCESSWIRE / February 23, 2021 / BioLineRx Ltd. (NASDAQ:BLRX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23, 2021 at 10:00 AM Eastern Time.
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the year ended December 31, 2020 and provides a corporate update.